Category Archives: People

Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform

Transaction positions the combined company to execute a capital-efficient, repeatable strategy leveraging public market access and Lōkahi Therapeutics ai²-driven asset sourcing, development, and advancement platform RUTHERFORD, N.J. and LA JOLLA, Calif., July 14, 2026 (GLOBE NEWSWIRE) — Glucotrack, Inc. (Nasdaq: GCTK) today announced the completion of its strategic business combination with Lōkahi Therapeutics, establishing a […]

Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer

REVTORPYK is the first and only FDA-approved therapy that inhibits all class I PI3K isoforms (α, β, δ, γ) and mTOR complexes mTORC1 and mTORC2 In the Phase 3 VIKTORIA-1 trial, REVTORPYK combined with palbociclib and fulvestrant and REVTORPYK combined with fulvestrant reduced the risk of disease progression or death by 76% and 67%, respectively, compared […]

Bread Financial Announces Executive Leadership Changes

Valerie Greer, Executive Vice President and Chief Commercial Officer, to retire after nearly four decades in financial services Industry veteran Dennis McCarthy to be promoted to Executive Vice President and Chief Revenue Officer COLUMBUS, Ohio, July 14, 2026 (GLOBE NEWSWIRE) — Bread Financial® (NYSE: BFH), a tech-forward financial services company that provides simple, flexible payment, lending and saving solutions, today […]

Global Glyceryl Glucoside Market to Reach USD 39.0 Million by 2031, Driven by Bio-Based Skincare Innovation

The global glyceryl glucoside market is projected to grow from USD 30.2 million in 2026 to USD 39.0 million by 2031, at a 5.2% CAGR. Growth is driven by demand for bio-based moisturizing agents, clean beauty, premium skincare and dermaceuticals. Natural glyceryl glucoside leads the source segment, supported by sustainable ingredients and green chemistry. The […]

Two-Day Virtual U.S. GAAP Conference to Deliver Critical Accounting Standards and Financial Reporting Updates

Opportunities include U.S. GAAP training, CPE programs, technical accounting advisory, implementation support, reporting-change readiness, and tools that track standards, timelines, transition requirements, and compliance complexity. Dublin, July 14, 2026 (GLOBE NEWSWIRE) — The “Financial Accounting & Reporting Update 2026 (Nov 18th – Nov 19th, 2026)” event has been added to ResearchAndMarkets.com’s offering. Finance and accounting […]

Roofing Tiles Market Size to Surpass USD 21.87 Billion by 2035 on Rising Sustainable Construction Demand | SNS Insider

U.S. Market to Reach USD 3.89 Billion by 2035, While Europe Expands to USD 6.82 Billion Amid Energy-Efficient Building Adoption Austin, July 14, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, The Roofing Tiles Market was valued at USD 12.73 Billion in 2025 and is projected to reach USD 21.87 Billion by 2035, expanding at […]

Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress

Sutacimig Phase 2 long-term extension (LTE) data show sustained bleed reduction and manageable safety and tolerability; Phase 3 initiation planned 2H 2026 Preclinical data for sutacimig in Factor VII deficiency (FVIID) demonstrate restoration of thrombin generation under disease-mimicking conditions and support its potential as a pan-hemostatic agent Natural history studies in Glanzmann thrombasthenia (GT) confirm […]

Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring

Updated NCCN language continues to support CSF analysis in the diagnosis and management of leptomeningeal metastases, including CSF cytology follow-up every 4 to 8 weeks for patients receiving intrathecal therapy, to enable longitudinal patient monitoring HOUSTON, July 14, 2026 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), today highlighted the recent […]